Appital is an emerging financial market platform that will use digital profiling, unique algorithms and notifications to connect institutional demand and supply. With Appital, corporate and institutional companies within the equity capital markets space will have the opportunity to exchange illiquid equity without an investment bank or broker. Appital will also remove the dependence on email and phone, thereby ensuring efficiency and accessibility. The company is raising fund to built the Appital software, achieve FCA regulation, generate marketing material and gain contracts with partner settlement and KYC providers. Furthermore, the company will enhance the functionality of the software by leveraging its network to other products such as primary debt and primary equity deal flow.
days to go:
Expired
investment:
£349,060
SortFlow's proprietary software solution intends to optimise the design and operation of waste recovery and recycling plants. The company argues that the UK, Europe and North America are expected to increase their recycling capacity over the next decade, which requires building more sorting and recycling facilities and maximising the amount of waste they can process. SortFlow claims its software can help the aforementioned parties save time, recycle more materials, and be more profitable. SortFlow released Version 1 of its software in October 2020, which is still being used in 5 countries by early adopter customers, including leading industry players such as Suez & Bollegraaf. SortFlow intends to release Version 2 later in 2021 and commercially roll it out to the broader market. The company aspires to become a contender in the waste management industry valued at an estimated £295 billion. It states it will use the investment to accelerate its growth by investing in product development, boosting its sales and marketing effort, and growing its team.
days to go:
Expired
investment:
£339,957
Simply get results limited are a universal data analytics solution, improving financial performance through people. They have established a client portfolio of household names and are profitable with over £400k of revenue. They save organisations tens of millions of pounds using their proprietary software and unique algorithms to find patterns and trends to present unseen opportunities.
days to go:
Expired
investment:
£205,000
BiVictriX Therapeutics is a pharmaceutical company that are developing ADC's (Antibody Drug Conjugates) in the field of Oncology. They have invented a strategy that improves ADC selectivity towards cancer cells.
days to go:
Expired
investment:
£451,506
Ding have created a beautiful and simple doorbell which compliments rather than distracts from your home. The smart doorbell has a chime just as an ordinary bell does but also calls you on your phone so you are able to carry your doorbell wherever you go.
days to go:
Expired
investment:
£97,200
Recap is a cryptocurrency portfolio tracking, analytics and tax reporting platform. The company claims that market participants engaging in cryptocurrency have to deal with complex issues such as tracking all of their transactions, valuing cryptocurrency transactions in their tax currency and understanding capital gains tax legislation laws. Recap aims to solve this issue by enabling said participants to calculate any tax they owe on their cryptocurrency trading activity in a matter of seconds on its portal. The company has plans to launch a mobile application enabling investors to track their portfolio on the move. It also intends to come up with a Business-to-business (B2B) offering which Recap asserts will enable crypto native companies to account for their cryptocurrency activity with automatic accounts reconciliation to accounting software like Xero and Quickbooks. The company’s exit strategy is a trade sale within 3-5 years to a cryptocurrency exchange or accounting software provider.
days to go:
Expired
investment:
£120,472
PLAYin CHOC is an ethical UK manufacturer that makes chocolate and plastic-free toys sustainably. The company asserts that it currently has a range of 19 products that are plastic-free, organic, vegan certified, and free from 14 allergens. It aspires to become a contender in the global chocolate with toy market segment that is worth 4 billion USD per annum. PLAYin CHOC claims that its distributors have access to over 600,000 shops across 30 countries. PLAYin CHOC points out that it is listed with 3 global companies, Sysco, Ocado and Gategroup, and is in early-stage conversations with 'Top 5' supermarkets in the UK. The company has also won 18 multi-national awards and exports its products to 30 countries. It argues that its UK factory has the capacity to produce 33,000 bars in 8 hours. PLAYin CHOC will use the investment to scale its business across different verticals.
days to go:
Expired
investment:
£364,495
MiiCARE is a company that provides AI-based in-home companionship & health support for the elderly. miiCARE provides an 18-month product validation process with the NHS and the elderly. Its innovation miiCUBE is a cloud-based assistive technology solution that can detect an emergency and inform a designated responder. miiCARE already has 250 prospective clients who have already expressed interest to purchase the product. The company was accepted for the 'Microsoft for Startups' program in 2019 and Microsoft's 'AI for Good' acceleration cohort in 2020. The company will utilise the investments to create an emergency stock to support future orders, fulfill orders for clients, strengthen its team, and create a small inventory for orders.
days to go:
Expired
investment:
£354,632
Skinny Tonic (ST) aims to change the traditional soft drink market by creating 100% natural, zero-sugar, zero-calorie soft drinks. The company raised £1.8 million in its first Seedrs raise in January 2020. It also raised £1.75 million in conjunction with the UK Future Fund and received the Food Matters Award for 'New drink product of the year'. ST also launched four flavours into 27 Booths stores in June 2020. It will use the investment to pioneer New Product Development (NPD), achieve British Retail Consortium (BRC) accreditation, continue to invest in staff training and recruitment, launch its fully automated canning and bottling facility, and grow the business across different verticals.
days to go:
Expired
investment:
£2,433,839
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£326,190
